Acute urinary morbidity following I-125 prostate brachytherapy

International Journal of Clinical Oncology

Volumn 10, Issue 4, 2005, Pages 262-268

  Ohashi, Toshio ^a   Yorozu, Atsunori ^a   Toya, Kazuhito ^a   Saito, Shiro ^a   Momma, Tetsuo ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Brachytherapy; Catheterization; Iodine 125; Prostate cancer; Urinary morbidity

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CATHETERIZATION; DYSURIA; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; URINARY FREQUENCY; URINARY TRACT DISEASE; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; URINE RETENTION;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; JAPAN; MALE; MIDDLE AGED; PALLADIUM; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOPHARMACEUTICALS; URINARY TRACT; URINATION DISORDERS;

EID: 24144478966     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-005-0507-8     Document Type: Article

References (29)

1. O Pasteau P Degrais 1914 The radium treatment of cancer of the prostate Arch Roentgenol Ray 18 396 410
2. WF Whitmore B Hilaris H Grabstald 1972 Retropubic implantation of iodine-125 in the treatment of prostate cancer J Urol 108 918 920
3. HH Holm N Juul JF Pedersen 1983 Transperineal iodine-125 seed implantation in prostatic cancer guided transrectal ultrasonography J Urol 130 283 286
4. S Nag W Bice K DeWyngaert 2000 The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis Int J Radiat Oncol Biol Phys 46 221 230
5. BH Han KC Demel K Wallner 2001 Patient reported complications after prostate brachytherapy J Urol 166 953 957
6. GS Merrick WM Butler JH Life 2000 Temporal resolution of urinary morbidity following prostate brachytherapy Int J Radiat Oncol Biol Phys 47 121 128
7. P Wust DW Borczyskowski T Henkel 2004 Clinicaland physical determinants for toxicity of 125-I seed prostate brachytherapy Radiother Oncol 73 39 48
8. JC Blasko H Ragde PD Grimm 1991 Transperineal ultrasound-guided implantation of the prostate: morbidity and complications Scand J Urol Nephrol Suppl 137 113 118
9. KW Kaye DJ Olson JT Payne 1995 Detailed preliminary analysis of 125-iodine implantation for localized prostate cancer using percutaneous approach J Urol 153 1020 1025
10. M Dattoli K Wallner R Sorace 1996 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma Int J Radiat Oncol Biol Phys 35 875 879
11. N Lee C Wuu R Brody 2000 Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 48 1457 1460
12. J Bucci WJ Morris M Keyes 2002 Predictive factors of urinary retention following prostate brachytherapy Int J Radiat Oncol Biol Phys 53 91 98
13. DJ Schwartz SE Schild WW Wong 2005 Factorsassociated with the frequency of self-intermittent catheterization after prostate brachytherapy Int J Radiat Oncol Biol Phys 61 60 63
14. D Fleming American Joint Committee on Cancer, NationalCancer Institute (US) 1997 AJCC cancer staging manual Lippincott-Raven Philadelphia
15. A Trotti AD Colevas A Setser 2003 CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 176 181
16. H Ragde AA Elgamal PB Snow 1998 Ten-year disease-free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma Cancer 83 989 1001
17. H Ragde JC Blasko PD Grimm 1997 Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate cancer Cancer 80 442 453
18. H Ragde JC Blasko PD Grimm 1997 Brachytherapy for clinically localized prostate cancer: results at 7 and 8 year follow-up Semin Surg Oncol 13 438 443
19. N Salem M Simonian-Sauve R Rosello 2003 Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localized prostate cancer: a phase 2 study Radiother Oncol 66 159 165
20. 125I brachytherapy of the prostate Br J Urol 92 555 558
21. FJ Fowler Jr MJ Barry G Lu-Yao 1993 Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993) Urology 42 622 629
22. DY Gelblum L Potters R Ashley 1997 Urinary morbidity following ultrasound-guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys 45 59 67
23. K Wallner H Lee S Wasserman M Dattoli 1997 Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection Int J Radiat Oncol Biol Phys 37 565 569
24. MD Terk RG Stock NN Stone 1998 Identification of patientsat increased risk for prolonged urinary retention followingradioactive seed implantation of the prostate J Urol 160 1379 1382
25. J Crook M McLean C Catton 2002 Factors influencingrisk of acute urinary retention after TRUS-guided permanentprostate seed implantation Int J Radiat Oncol Biol Phys 52 453 460
26. GS Merrick WM Butler KE Wallner 2004 The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy Brachytherapy 3 22 29
27. BR Prestidge WS Bice EJ Kiefer 1998 Timing ofcomputed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy Int J Radiat Oncol Biol Phys 40 1111 1115
28. FM Waterman AP Dicker 2002 Impact of postimplant edema on V100 and D90 in prostate brachytherapy: can implant quality be predicted on day 0? Int J Radiat Oncol Biol Phys 53 610 621
29. TG Shanahan PW Mueller DA Roszhart 2004 Image guided I 125 prostate brachytherapy with hybrid interactive Mick technique in the community setting: how does it compare? Technol Cancer Res Treat 3 209 215